LinkOPH

Alimera Sciences reported second quarter net revenue of $2.2 million, up from $2.1 million in the first quarter and $179,000 in the same quarter of 2013, the company announced in a news release.“We achieved an important milestone during the second quarter of 2014 as more commercial patients have now been injected with Iluvien than were treated in our clinical trials. Further, we experienced a 25% increase in Iluvien injections in the United Kingdom during the second quarter of 2014 compared to the prior quarter,” Dan Myers, Alimera president and CEO, (Read more...)

Adult strabismus patients who underwent corrective surgery demonstrated beneficial gains in their ocular misalignment and improvement in quality of life, according to study findings.The study included 31 patients older than 15 years of age with strabis…

Read more →

Multimodal fundus imaging enabled classification of pseudodrusen into three subtypes, according to a study.Investigators used color fundus photography, infrared scanning laser ophthalmoscopy (IR-SLO) and spectral-domain optical coherence tomography to …

Read more →

Torpedo maculopathy can be distinguished from other posterior segment lesions with similar features, according to a report.Congenital hypertrophy of the retinal pigment epithelium (CHRPE) and retinal pigment epithelial (RPE) lesions of Gardner syndrome…

Read more →

We’ve been battling the “forces of evil” when it comes to the prescription of topical NSAIDs and cataract surgery. Insurance companies and public-private mixes not only routinely demand generic prescriptions, but pharmacies quite often only stock the lowest priced among these generics.As a dry eye doc, this is particularly maddening because the side effects of these generics (eg, ketorolac, diclofenac) are much more commonly seen in my experience in patients with pre-existing dry eye syndrome (DES), decreasing the likelihood that they will take this important medicine.

Read more →